aminosalicylic acid has been researched along with sulfamethoxazole in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Cantilena, LR; Collins, JM; Katki, AG; Klecker, RW | 1 |
| Deng, JY; Gu, J; Li, K; Wang, XD; Yang, SS; Zhang, XE | 1 |
| Chen, SY; Deng, JY; Gao, YR; Gu, J; Hu, YB; Li, K; Wang, XD; Yang, SS; Zhang, TY; Zhang, XE | 1 |
1 trial(s) available for aminosalicylic acid and sulfamethoxazole
| Article | Year |
|---|---|
Metabolism by N-acetyltransferase 1 in vitro and in healthy volunteers: a prototype for targeted inhibition.
Topics: Adult; Aminosalicylic Acid; Area Under Curve; Arylamine N-Acetyltransferase; Cells, Cultured; Culture Techniques; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Delivery Systems; Female; Hepatocytes; Humans; Isoenzymes; Male; Middle Aged; Sulfamethoxazole | 2004 |
6 other study(ies) available for aminosalicylic acid and sulfamethoxazole
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Anti-folates potentiate bactericidal effects of other antimicrobial agents.
Topics: Aminosalicylic Acid; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Bacteria; Drug Synergism; Escherichia coli; Folic Acid Antagonists; Isoniazid; Microbial Sensitivity Tests; Mycobacterium smegmatis; Mycobacterium tuberculosis; Rifampin; Salmonella typhimurium; Staphylococcus aureus; Sulfamethoxazole | 2017 |
Deletion of
Topics: 4-Aminobenzoic Acid; Aminosalicylic Acid; Antitubercular Agents; Bacterial Proteins; Folic Acid; Gene Deletion; Lyases; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Sigma Factor; Sulfamethoxazole | 2017 |